These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 27130436)

  • 1. Dengue Virus Immunopathogenesis: Lessons Applicable to the Emergence of Zika Virus.
    Olagnier D; Amatore D; Castiello L; Ferrari M; Palermo E; Diamond MS; Palamara AT; Hiscott J
    J Mol Biol; 2016 Aug; 428(17):3429-48. PubMed ID: 27130436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dengue and Zika viruses: lessons learned from the similarities between these Aedes mosquito-vectored arboviruses.
    Suwanmanee S; Luplertlop N
    J Microbiol; 2017 Feb; 55(2):81-89. PubMed ID: 28120186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dengue, Zika and Chikungunya].
    Kantor IN
    Medicina (B Aires); 2016; 76(2):93-7. PubMed ID: 26942903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arbovirus vectors of epidemiological concern in the Americas: A scoping review of entomological studies on Zika, dengue and chikungunya virus vectors.
    Jones R; Kulkarni MA; Davidson TMV; ; Talbot B
    PLoS One; 2020; 15(2):e0220753. PubMed ID: 32027652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior Heterologous Flavivirus Exposure Results in Reduced Pathogenesis in a Mouse Model of Zika Virus Infection.
    Hassert M; Steffen TL; Scroggins S; Coleman AK; Shacham E; Brien JD; Pinto AK
    J Virol; 2021 Jul; 95(16):e0057321. PubMed ID: 34076486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High resolution proteomics of Aedes aegypti salivary glands infected with either dengue, Zika or chikungunya viruses identify new virus specific and broad antiviral factors.
    Chowdhury A; Modahl CM; Missé D; Kini RM; Pompon J
    Sci Rep; 2021 Dec; 11(1):23696. PubMed ID: 34880409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status, challenges and perspectives in the development of vaccines against yellow fever, dengue, Zika and chikungunya viruses.
    Silva JVJ; Lopes TRR; Oliveira-Filho EF; Oliveira RAS; Durães-Carvalho R; Gil LHVG
    Acta Trop; 2018 Jun; 182():257-263. PubMed ID: 29551394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of Aedes (Stegomyia) aegypti (Linnaeus, 1762) and its natural infection with dengue virus at unrecorded heights in Colombia.
    Ruiz-López F; González-Mazo A; Vélez-Mira A; Gómez GF; Zuleta L; Uribe S; Vélez-Bernal ID
    Biomedica; 2016 Jun; 36(2):303-8. PubMed ID: 27622492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate Antiviral Immunity against Dengue Virus.
    Makhluf H; Shresta S
    Crit Rev Immunol; 2015; 35(3):253-60. PubMed ID: 26559229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Update on Dengue, Chikungunya, and Zika: What We Know at the Time of Article Submission.
    Liu LE; Dehning M; Phipps A; Swienton RE; Harris CA; Klein KR
    Disaster Med Public Health Prep; 2017 Jun; 11(3):290-299. PubMed ID: 27572514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated human-virus metabolic stoichiometric modelling predicts host-based antiviral targets against Chikungunya, Dengue and Zika viruses.
    Aller S; Scott A; Sarkar-Tyson M; Soyer OS
    J R Soc Interface; 2018 Sep; 15(146):. PubMed ID: 30209043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal tripartite interactions between the Aedes aegypti midgut microbiota, innate immune system and dengue virus influences vector competence.
    Ramirez JL; Souza-Neto J; Torres Cosme R; Rovira J; Ortiz A; Pascale JM; Dimopoulos G
    PLoS Negl Trop Dis; 2012; 6(3):e1561. PubMed ID: 22413032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipids and flaviviruses, present and future perspectives for the control of dengue, Zika, and West Nile viruses.
    Martín-Acebes MA; Vázquez-Calvo Á; Saiz JC
    Prog Lipid Res; 2016 Oct; 64():123-137. PubMed ID: 27702593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zika Virus Emergence and Expansion: Lessons Learned from Dengue and Chikungunya May Not Provide All the Answers.
    Christofferson RC
    Am J Trop Med Hyg; 2016 Jul; 95(1):15-8. PubMed ID: 26903610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis and virulence of flavivirus infections.
    van Leur SW; Heunis T; Munnur D; Sanyal S
    Virulence; 2021 Dec; 12(1):2814-2838. PubMed ID: 34696709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dengue Antibody and Zika: Friend or Foe?
    Durbin AP
    Trends Immunol; 2016 Oct; 37(10):635-636. PubMed ID: 27599407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host immune response against DENV and ZIKV infections.
    Sekaran SD; Ismail AA; Thergarajan G; Chandramathi S; Rahman SKH; Mani RR; Jusof FF; Lim YAL; Manikam R
    Front Cell Infect Microbiol; 2022; 12():975222. PubMed ID: 36159640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Accuracy of Parameters for Zika and Dengue Virus Infections, Singapore.
    Ho HJ; Wong JGX; Mar Kyaw W; Lye DC; Leo YS; Chow A
    Emerg Infect Dis; 2017 Dec; 23(12):2085-2088. PubMed ID: 29148371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zika enhancement: a reality check.
    Mahalingam S; Teixeira MM; Halstead SB
    Lancet Infect Dis; 2017 Jul; 17(7):686-688. PubMed ID: 28653626
    [No Abstract]   [Full Text] [Related]  

  • 20. A conceptual model for optimizing vaccine coverage to reduce vector-borne infections in the presence of antibody-dependent enhancement.
    Tang B; Huo X; Xiao Y; Ruan S; Wu J
    Theor Biol Med Model; 2018 Sep; 15(1):13. PubMed ID: 30173664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.